In the US, Lyphocin (vancomycin systemic) is a member of the drug class glycopeptide antibiotics and is used to treat Bacteremia, Bacterial Endocarditis Prevention, Bacterial Infection, Bone infection, Burns - External, Endocarditis, Enterocolitis, Febrile Neutropenia, Meningitis, Methicillin-Resistant Staphylococcus Aureus Infection, Nosocomial Pneumonia, Peritonitis, Pneumonia, Prevention of Perinatal Group B Streptococcal Disease, Pseudomembranous Colitis, Sepsis, Shunt Infection, Skin Infection and Surgical Prophylaxis.
US matches:
- Lyphocin
Ingredient matches for Lyphocin
Vancomycin
Vancomycin hydrochloride (a derivative of Vancomycin) is reported as an ingredient of Lyphocin in the following countries:
- Hong Kong
International Drug Name Search
No comments:
Post a Comment